These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 21720875)

  • 1. Immunologically restricted patients exhibit a pronounced inflammation and inadequate response to hypoxia in fracture hematomas.
    Hoff P; Gaber T; Schmidt-Bleek K; Sentürk U; Tran CL; Blankenstein K; Lütkecosmann S; Bredahl J; Schüler HJ; Simon P; Wassilew G; Unterhauser F; Burmester GR; Schmidmaier G; Perka C; Duda GN; Buttgereit F
    Immunol Res; 2011 Oct; 51(1):116-22. PubMed ID: 21720875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human early fracture hematoma is characterized by inflammation and hypoxia.
    Kolar P; Gaber T; Perka C; Duda GN; Buttgereit F
    Clin Orthop Relat Res; 2011 Nov; 469(11):3118-26. PubMed ID: 21409457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Pronounced Inflammatory Activity Characterizes the Early Fracture Healing Phase in Immunologically Restricted Patients.
    Hoff P; Gaber T; Strehl C; Jakstadt M; Hoff H; Schmidt-Bleek K; Lang A; Röhner E; Huscher D; Matziolis G; Burmester GR; Schmidmaier G; Perka C; Duda GN; Buttgereit F
    Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28282868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human immune cells' behavior and survival under bioenergetically restricted conditions in an in vitro fracture hematoma model.
    Hoff P; Maschmeyer P; Gaber T; Schütze T; Raue T; Schmidt-Bleek K; Dziurla R; Schellmann S; Lohanatha FL; Röhner E; Ode A; Burmester GR; Duda GN; Perka C; Buttgereit F
    Cell Mol Immunol; 2013 Mar; 10(2):151-8. PubMed ID: 23396474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional Scaffold-Free Bone Equivalents Induce Osteogenic and Angiogenic Processes in a Human In Vitro Fracture Hematoma Model.
    Pfeiffenberger M; Damerau A; Ponomarev I; Bucher CH; Chen Y; Barnewitz D; Thöne-Reineke C; Hoff P; Buttgereit F; Gaber T; Lang A
    J Bone Miner Res; 2021 Jun; 36(6):1189-1201. PubMed ID: 33534144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunological characterization of the early human fracture hematoma.
    Hoff P; Gaber T; Strehl C; Schmidt-Bleek K; Lang A; Huscher D; Burmester GR; Schmidmaier G; Perka C; Duda GN; Buttgereit F
    Immunol Res; 2016 Dec; 64(5-6):1195-1206. PubMed ID: 27629117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compromised Bone Healing in Aged Rats Is Associated With Impaired M2 Macrophage Function.
    Löffler J; Sass FA; Filter S; Rose A; Ellinghaus A; Duda GN; Dienelt A
    Front Immunol; 2019; 10():2443. PubMed ID: 31681320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The in vitro human fracture hematoma model - a tool for preclinical drug testing.
    Pfeiffenberger M; Hoff P; Thöne-Reineke C; Buttgereit F; Lang A; Gaber T
    ALTEX; 2020; 37(4):561-578. PubMed ID: 32521037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The early fracture hematoma and its potential role in fracture healing.
    Kolar P; Schmidt-Bleek K; Schell H; Gaber T; Toben D; Schmidmaier G; Perka C; Buttgereit F; Duda GN
    Tissue Eng Part B Rev; 2010 Aug; 16(4):427-34. PubMed ID: 20196645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement receptors C5aR1 and C5aR2 act differentially during the early immune response after bone fracture but are similarly involved in bone repair.
    Kovtun A; Bergdolt S; Hägele Y; Matthes R; Lambris JD; Huber-Lang M; Ignatius A
    Sci Rep; 2017 Oct; 7(1):14061. PubMed ID: 29070810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time Course of Immune Response and Immunomodulation During Normal and Delayed Healing of Musculoskeletal Wounds.
    Muire PJ; Mangum LH; Wenke JC
    Front Immunol; 2020; 11():1056. PubMed ID: 32582170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoxia and mesenchymal stromal cells as key drivers of initial fracture healing in an equine in vitro fracture hematoma model.
    Pfeiffenberger M; Bartsch J; Hoff P; Ponomarev I; Barnewitz D; Thöne-Reineke C; Buttgereit F; Gaber T; Lang A
    PLoS One; 2019; 14(4):e0214276. PubMed ID: 30947253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxia promotes osteogenesis but suppresses adipogenesis of human mesenchymal stromal cells in a hypoxia-inducible factor-1 dependent manner.
    Wagegg M; Gaber T; Lohanatha FL; Hahne M; Strehl C; Fangradt M; Tran CL; Schönbeck K; Hoff P; Ode A; Perka C; Duda GN; Buttgereit F
    PLoS One; 2012; 7(9):e46483. PubMed ID: 23029528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The immune microenvironment of human fracture/soft-tissue hematomas and its relationship to systemic immunity.
    Hauser CJ; Zhou X; Joshi P; Cuchens MA; Kregor P; Devidas M; Kennedy RJ; Poole GV; Hughes JL
    J Trauma; 1997 May; 42(5):895-903; discussion 903-4. PubMed ID: 9191672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic Intermittent Hypobaric Hypoxia Enhances Bone Fracture Healing.
    Zhang L; Jin L; Guo J; Bao K; Hu J; Zhang Y; Hou Z; Zhang L
    Front Endocrinol (Lausanne); 2020; 11():582670. PubMed ID: 33664707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SDF-1/CXCR4 axis in Tie2-lineage cells including endothelial progenitor cells contributes to bone fracture healing.
    Kawakami Y; Ii M; Matsumoto T; Kuroda R; Kuroda T; Kwon SM; Kawamoto A; Akimaru H; Mifune Y; Shoji T; Fukui T; Kurosaka M; Asahara T
    J Bone Miner Res; 2015 Jan; 30(1):95-105. PubMed ID: 25130304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hematoma-inspired alginate/platelet releasate/CaPO4 composite: initiation of the inflammatory-mediated response associated with fracture repair in vitro and ex vivo injection delivery.
    McCanless JD; Jennings LK; Bumgardner JD; Cole JA; Haggard WO
    J Mater Sci Mater Med; 2012 Aug; 23(8):1971-81. PubMed ID: 22588505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-intensity pulsed ultrasound affects RUNX2 immunopositive osteogenic cells in delayed clinical fracture healing.
    Rutten S; Nolte PA; Korstjens CM; Klein-Nulend J
    Bone; 2009 Nov; 45(5):862-9. PubMed ID: 19631773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Initial immune reaction and angiogenesis in bone healing.
    Schmidt-Bleek K; Schell H; Lienau J; Schulz N; Hoff P; Pfaff M; Schmidt G; Martin C; Perka C; Buttgereit F; Volk HD; Duda G
    J Tissue Eng Regen Med; 2014 Feb; 8(2):120-30. PubMed ID: 22495762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fracture repair in the elderly: Clinical and experimental considerations.
    Meinberg EG; Clark D; Miclau KR; Marcucio R; Miclau T
    Injury; 2019 Jun; 50 Suppl 1(Suppl 1):S62-S65. PubMed ID: 31130210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.